Evidence map›Paper›PMID 39170804›Full record

ArticleVeterinarni medicina2022

Riboflavin/UV-A corneal phototherapy as stand-alone management of ulcerative keratitis in dogs.

Andrea Marchegiani, Rodolfo Gialletti, Maria Paola Cassarani, Matteo Cerquetella, Anna Rita Attili, Giuseppe Lombardo, Marco Lombardo, Andrea Spaterna, Rolando Arcelli

Abstract read
In one paragraph

Article in Veterinarni medicina, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrea MarchegianiSchool of Biosciences and Veterinary Medicine, University of Camerino, Matelica (Macerata), Italy.
Rodolfo GiallettiDepartment of Veterinary Medicine, University of Perugia, Perugia, Italy.
Maria Paola CassaraniSchool of Biosciences and Veterinary Medicine, University of Camerino, Matelica (Macerata), Italy.
Matteo CerquetellaSchool of Biosciences and Veterinary Medicine, University of Camerino, Matelica (Macerata), Italy.
Anna Rita AttiliSchool of Biosciences and Veterinary Medicine, University of Camerino, Matelica (Macerata), Italy.
Giuseppe LombardoCNR-IPCF, Istituto per i Processi Chimico-Fisici, Messina, Italy.
Marco LombardoVision Engineering Italy srl, Rome, Italy.
Andrea SpaternaSchool of Biosciences and Veterinary Medicine, University of Camerino, Matelica (Macerata), Italy.
Rolando ArcelliDepartment of Veterinary Medicine, University of Perugia, Perugia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corneal ulcers are one of the most common ocular disorders in veterinary ophthalmology and several factors can negatively influence the efficacy of the currently available therapeutic options, leading to a loss of corneal transparency and, thus, vision. Twenty-five dogs with clinical signs of corneal ulcers were randomised to receive either corneal phototherapy (16 dogs; study group) or topical standard medical therapy (9 dogs; control group). The riboflavin/UV-A corneal phototherapy (PACK-CXL) consisted in the application of a riboflavin ophthalmic solution (Visioflavin

Indexed as

corneal meltingcorneal ulcercross-linkingkeratitisriboflavin; UV-A

Identifiers

PMID39170804
PMCPMC11334441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.